Clinical Trial: Clinical Performance of Atypical Contact Lens Powers on Subjects With Astigmatism
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title:
Brief Summary: This study will evaluate the fitting characteristics and physiological response of two toric lenses manufactured by Vistakon.
Detailed Summary:
Sponsor: Johnson & Johnson Vision Care, Inc.
Current Primary Outcome:
- Assessment of Conjunctival Hyperemia in Subjects That Are High Myopes (Have a High Degree of Nearsightedness) [ Time Frame: after 6 hours of wear ]Conjunctival hyperemia measures the redness across the white of the eye. The investigator used a grading scale of 0=none, 1=slight, 2=moderate, 3=severe.
- Assessment of Conjunctival Hyperemia in Subjects That Are Hyperopes (Farsighted) [ Time Frame: after 6 hours of wear ]Conjunctival hyperemia measures the redness across the white of the eye. The investigator used a grading scale of 0=none, 1=slight, 2=moderate, 3=severe.
- Assessment of Conjunctival Hyperemia in Subjects That Are Oblique Astigmats (Have an Abnormally Curved Cornea) [ Time Frame: after 6 hours of wear ]Conjunctival hyperemia measures the redness across the white of the eye. The investigator used a grading scale of 0=none, 1=slight, 2=moderate, 3=severe.
- Assessment of Limbal Hyperemia in Subjects That Are High Myopes (Have a High Degree of Nearsightedness) [ Time Frame: after 6 hours of wear ]Limbal hyperemia measures the redness around the edge of the cornea. The investigator used a grading scale of 0=none, 1=slight, 2=moderate, 3=severe.
- Assessment of Limbal Hyperemia in Subjects That Are Hyperopes (Farsighted) [ Time Frame: after 6 hours of wear ]Limbal hyperemia measures the redness around the edge of the cornea. The investigator used a grading scale of 0=none, 1=slight, 2=moderate, 3=severe.
Original Primary Outcome: Physical fit [ Time Frame: after 6 hours of wear ]
Current Secondary Outcome:
Original Secondary Outcome: Physiology. [ Time Frame: after 6 hours of wear ]
Information By: Johnson & Johnson Vision Care, Inc.
Dates:
Date Received: June 10, 2008
Date Started: May 2008
Date Completion:
Last Updated: May 6, 2015
Last Verified: May 2015